Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069780
Filing Date
2025-05-13
Accepted
2025-05-13 07:00:34
Documents
49
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-20250331.htm   iXBRL 10-Q 924901
2 EX-31.1 nerv-ex31_1.htm EX-31.1 16380
3 EX-31.2 nerv-ex31_2.htm EX-31.2 15910
4 EX-32.1 nerv-ex32_1.htm EX-32.1 14073
  Complete submission text file 0000950170-25-069780.txt   4672664

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nerv-20250331.xsd EX-101.SCH 831948
52 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20250331_htm.xml XML 658212
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 25937081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)